BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 150 filers reported holding BIONTECH SE in Q3 2020. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $24,475,514 | -26.3% | 196,480 | -11.1% | 0.36% | -19.5% |
| Q4 2022 | $33,210,638 | +60.3% | 221,080 | +44.0% | 0.44% | +48.5% |
| Q3 2022 | $20,715,000 | -8.1% | 153,580 | +1.6% | 0.30% | -6.9% |
| Q2 2022 | $22,544,000 | +18.3% | 151,200 | +35.3% | 0.32% | +44.3% |
| Q1 2022 | $19,063,000 | -34.8% | 111,766 | -1.5% | 0.22% | -26.8% |
| Q4 2021 | $29,252,000 | +743.7% | 113,466 | +793.4% | 0.30% | +762.9% |
| Q3 2021 | $3,467,000 | -31.5% | 12,700 | -43.8% | 0.04% | -28.6% |
| Q2 2021 | $5,060,000 | +1.9% | 22,600 | -50.3% | 0.05% | -7.5% |
| Q1 2021 | $4,968,000 | +238.7% | 45,500 | +152.8% | 0.05% | +211.8% |
| Q4 2020 | $1,467,000 | -57.2% | 18,000 | -63.6% | 0.02% | -63.8% |
| Q3 2020 | $3,427,000 | +2.7% | 49,500 | -1.0% | 0.05% | 0.0% |
| Q2 2020 | $3,337,000 | – | 50,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |